Industry News

Depomed, Inc. today announced that Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of Abbreviated New Drug Applications for Depomed's NUCYNTA franchise. With the court’ s ruling, Depomed expects market exclusivity until December 2025 for NUCYNTA ® ER, NUCYNTA ® and NUCYNTA ® oral solution. 1. “We are pleased with the Court’ s..."/>
Depomed Prevails in NUCYNTA Franchise ANDA Litigation Providing Market Exclusivity Until December 2025
Prothena Corporation plc, announced today that its Co-founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed away this morning, after confronting his pancreatic cancer with the same courage, determination and humor that pervaded all areas of his life.. “Dale was a dear friend and colleague, and the broader scientific community has lost an incredibly innovative and creative leader,” stated Lars G. Ekman, MD, PhD, Chairman of the Prothena..."/>
In Memoriam – Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away
Aetna today declared a quarterly cash dividend of $0.25 per share on the company’ s common stock. The dividend is payable on October 28, 2016, to shareholders of record at the close of business on October 13, 2016.. Declaration and payment of future dividends is at the discretion of the Board and may be adjusted as business needs or market conditions change."/>
Aetna Board of Directors Declares Quarterly Cash Dividend
Novocure, Ltd., please note that the first paragraph should say "the three and nine months ended Sept. 30, 2016" rather than "the three and six months ended Sept. 30, 2016" as previously stated. Novocure to Report Third Quarter 2016 Financial Results. Novocure announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of..."/>
CORRECTING and REPLACING – Novocure to Report Third Quarter 2016 Financial Results
WEX Inc. have a new perk: up to six weeks of fully paid parental leave for the birth or adoption of a child. The South Portland payment processing technology firm has joined a small but growing list of employers that offer paid leave to both male and female employees for childbirth and adoption. WEX implemented the new policy Sept. 1, retroactive to the beginning of this year."/>
WEX embraces new parental leave policy to attract, keep workers [Portland Press Herald, Maine]
Aetna today announced a new value-based collaboration with Baptist Health& St. Vincent’ s HealthCare to deliver care more efficiently. Together, they will offer employers and employees in Clay, Duval and St."/>
Aetna Introduces New Value-Based Care Collaboration with Baptist Health & St. Vincent’s HealthCare
Kinepolis sells Belgian Utopolis cinemas to UGC
Chartwell Retirement Residences, we are advised by the company that the first sentence of the second paragraph should read, "A conference call hosted by Brent Binions, President and Chief Executive Officer, Vlad Volodarski, Chief Financial Officer and Chief Investment Officer and Karen Sullivan, Chief Operating Officer will be held Thursday, November..."/>
CORRECTION - Chartwell Third Quarter 2016 Results and Conference Call
Seres Therapeutics, Inc. concerning possible violations of federal securities laws between June 25, 2015 and July 29, 2016 inclusive. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the November 28, 2016 lead plaintiff motion deadline.. To participate in this class action lawsuit, click here."/>
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Invitae Corporation, was..."/>
Genetic Counselors Recognized by Patients, Peers for Excellence in Patient Care
Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its participation at the recent Congress of Neurological Surgeons Annual Meeting in San Diego, CA, which took place on September 24-28, 2016.."/>
Misonix Features BoneScalpel™ and SonaStar™ Systems at Congress of Neurological Surgeons ("CNS")
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, announced today that ReGenTree, RegeneRx's U.S. joint venture with GtreeBNT, initiated its second Phase 3 trial for Dry Eye Syndrome this month and will begin patient enrollment shortly. The double-masked, placebo-controlled trial is expected to enroll approximately 500 patients who will be treated for..."/>
RegeneRx Joint Venture Initiates Second Phase 3 Study Of RGN-259 for Dry Eye Syndrome
LivaNova PLC, a market-leading medical technology company, announced today its participation in the 30th European Association for Cardio-Thoracic Surgery Annual Meeting, October 1- 5, 2016, in Barcelona, Spain. At its exhibit and Tecnosuite in the CCBI Conference Center, LivaNova will celebrate several major patient treatment milestones for its Cardiac Surgery Business Unit and discuss the Company's campaign to "Cut Through Complexity" using..."/>
LivaNova PLC Announces Participation in 30th EACTS Annual Meeting
LivaNova PLC, a market-leading medical technology company, announced today its participation in the 30 th European Association for Cardio-Thoracic Surgery Annual Meeting, October 1– 5, 2016, in Barcelona, Spain.. At its exhibit and Tecnosuite in the CCBI Conference Center, LivaNova will celebrate several major patient treatment milestones for its Cardiac Surgery Business Unit and discuss the Company’ s campaign to“ Cut Through Complexity” using..."/>
LivaNova PLC Announces Participation in 30th EACTS Annual Meeting
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, will visit the Nasdaq MarketSite in Times Square, to kick off Breast Cancer Awareness Month for the 11 th consecutive year. In honor of the occasion, Steve MacMillan, Chairman, President and Chief Executive Officer and spokeswoman Sheryl Crow, will ring the Opening Bell. Where: Nasdaq MarketSite– 4 Times Square– 43 rd& Broadway– Broadcast..."/>
Breast Cancer Survivor and Grammy Award-Winner Sheryl Crow and Hologic, Inc. (Nasdaq: HOLX) to Ring The Nasdaq Stock Market Opening Bell
Cipla Ltd on Friday informed stock exchanges that said it got four observations from US Food and Drug Administration for three of its manufacturing facilities in Goa. "US FDA recently concluded audit of our three manufacturing facilities at Goa and has issued four observations across these three facilities," the company said. The company didn't specify the nature of the observations."/>
Cipla gets 4 observations from US FDA for its three plants in Goa [Mint, New Delhi]
Mylan Launches Generic Fortamet® Tablets
Det norske oljeselskap ASA: Primary Insider Notice
Emergent BioSolutions Inc. today provided an update on the status of its 2011 BioThrax ® procurement contract and the status of its discussions with the Centers for Disease Control and Prevention for a follow-on procurement contract for BioThrax.. 2011 Procurement Contract CDC has exercised an option to procure all remaining BioThrax doses, thereby committing to take delivery of the full 44.75 million doses, under the procurement contract..."/>
Emergent BioSolutions Provides Update on Status of BioThrax Procurement Contract and Discussions With CDC
Chartwell Retirement Residences will issue its financial results for the three and nine months ended September 30, 2016 on the afternoon of November 9, 2016.. A conference call hosted by Brent Binions, President and Chief Executive Officer, Vlad Volodarski, Chief Financial Officer and Chief Investment Officer and Karen Sullivan, Chief Operating Officer will be held Friday, November 10, 2016 at 10:00 AM ET. The telephone numbers for the conference..."/>
Chartwell Third Quarter 2016 Results and Conference Call
SunLink Health Systems, Inc. today announced a loss from continuing operations for its fourth fiscal quarter ended June 30, 2016 of $823,000 or a loss of $0.09 per fully diluted share, compared to a loss from continuing operations of $7,000 or a loss of $0.00 per fully diluted share, for the quarter ended June 30, 2015. Net loss for the quarter ended June 30, 2016 was $1,234,000, or a loss of $0.13 per fully diluted share, compared to net earnings of $92,000, or $0.01 per fully..."/>
SunLink Health Systems, Inc. Announces Fiscal 2016 Fourth Quarter and Full-Year Results
Delcath Systems, Inc., an interventional oncology company focused on treatments for primary and metastatic liver cancers, today announced the pricing of an underwritten public offering of 425,000 shares of its common stock at a price of $3.00 per share, for gross proceeds of $1,275,000. Investors will also receive 0.35 warrants to purchase an additional share of common stock at an initial exercise price of $3.00 per share, with a term of five years."/>
Delcath Prices Underwritten Public Offering of Common Stock and Warrants

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology756 Articles
Consumer Discretionary655 Articles
Financials508 Articles
Industrials427 Articles
Health Care426 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.